Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A revision/version label at the bottom of the page was updated from v3.5.2 to v3.5.3. This represents a change in the site’s release version rather than any modification to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:48.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer revision tag updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:24.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a new revision note, v3.5.0, and the previous revision note, v3.4.3, was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:22.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:23:43.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 tag; removed the prior funding/operating-status notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:15.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Site-wide notice about funding and data currency has been added, indicating the NIH Clinical Center is open and where to find operating status updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:33:01.000Z thumbnail image

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.